Optimizing Treatment Approaches for Localized Breast Cancer Patients

Exploring tailored treatment strategies for localized breast cancer patients, covering factors such as tumor size, receptor status, fertility preservation using GNRH analogs, systemic therapy options, potential cardiotoxic effects, management of residual disease in HER2-positive cases, neoadjuvant chemotherapy for inflammatory breast cancer, and considerations for breast cancer in pregnant patients. Emphasizing the significance of personalized approaches including mastectomy, axillary lymph node dissection, radiation, and chemotherapy, highlighting key treatments like pembrolizumab, carboplatin, kip cytobene, endocrine therapy, genomic assessment, and specific chemotherapy regimens based on oncotype and lymph node status.